Health Economic & Outcomes Research Strategy Lead (Belgium)

UCB S.A.; Anderlecht; Hybrid; EUR 120.000 - 165.000; Vollzeit

Zusammenfassung

UCB S.A. seeks an HEOR Strategy Lead to shape global payer evidence strategies across the product lifecycle. You will influence development programs and collaborate with Market Access, Real World Evidence, and Medical Affairs to ensure robust, payer-aligned evidence generation.

The role requires 8+ years in pharma, expertise in modelling and HTA submissions, and strong leadership for global, matrixed teams. Hybrid work in Brussels, with international collaboration.

Qualifikationen

• Master's degree or PhD in Health Economics, Market Access, Outcomes Research, Public Health, Epidemiology, Pharmacy, or related field.
• At least 8 years of experience in the pharmaceutical industry, including consultancy where relevant.
• Strong expertise in health economic modelling, outcomes research, and payer evidence generation.
• Experience supporting HTA submissions, reimbursement strategies, and access initiatives across key markets.
• Experience working in global or matrix organizations with cross-border exposure valued.
• Strong leadership, communication, stakeholder management, and strategic thinking skills.

Aufgaben

• Develop and continuously refine global HEOR and payer evidence strategies aligned with asset and market access objectives.
• Design and deliver key HEOR evidence generation activities, including cost-effectiveness models, budget impact models, systematic literature reviews, and health outcomes research.
• Develop asset value assessments and support economically justified pricing and value strategies.
• Build and communicate compelling economic value stories for assigned assets and indications.
• Influence clinical development programs to address payer and HTA requirements across EU markets.
• Represent HTA and payer perspectives within cross-functional evidence generation and development teams.
• Support the creation of global value dossiers and guide affiliate teams on reimbursement and access strategies.
• Partner with cross-functional stakeholders to execute studies strengthening payer decision-making.
• Integrate affiliate and market-specific payer requirements into global evidence generation plans.
• Contribute to scientific publications, congress presentations, external partnerships, and thought leadership.

Kenntnisse

HEOR

Strategic thinking

Leadership

Stakeholder management

Communication

Evidence generation

Ausbildung

Master's degree or PhD in Health Economics or related field

Jobbeschreibung

Make your mark for patients

We are looking for a Health Economics & Outcomes Research Strategy Lead who is strategic, analytical, and influential to join our Patient Evidence team, helping shape global evidence strategies that support successful payer, HTA, and reimbursement outcomes for UCB's portfolio based in Brussels, Belgium; Slough, UK or Monheim, Germany.

About the Role

As HEOR Strategy Lead, you will be responsible for developing and executing global Health Economics & Outcomes Research (HEOR) strategies aligned with HTA and payer evidence requirements across the product lifecycle.

You will act as a key member of the global payer sub-team, representing the HTA and payer perspective within evidence generation and clinical development activities. By identifying evidence gaps, informing development strategies, and connecting access objectives to robust evidence generation plans, you will play a critical role in enabling successful reimbursement and patient access.

This role offers the opportunity to influence strategic decisions from development through commercialization, ensuring evidence generation activities address the evolving needs of healthcare decision-makers worldwide.

Who You'll Work With

You will work closely with colleagues across Market Access, Patient Evidence, Real World Evidence, Patient Centered Outcomes Research, Biostatistics & Quantitative Sciences, Clinical Development, and Medical Affairs. You will also collaborate with affiliate teams, external experts, and research partners to ensure evidence generation strategies support successful access outcomes.

What You'll Do

• Develop and continuously refine global HEOR and payer evidence strategies aligned with asset and market access objectives.
• Design and deliver key HEOR evidence generation activities, including cost-effectiveness models, budget impact models, systematic literature reviews, indirect treatment comparisons, healthcare resource utilization studies, and quality-of-life research.
• Develop asset value assessments and support economically justified pricing and value strategies.
• Build and communicate compelling economic value stories for assigned assets and indications.
• Influence clinical development programs to ensure evidence generation plans address payer and HTA requirements, including evolving EU HTA needs.
• Represent HTA and payer perspectives within cross-functional evidence generation and development teams.
• Support the creation of global value dossiers and guide affiliate teams on reimbursement and access strategies.
• Partner with cross-functional stakeholders to execute studies that strengthen payer decision-making, including patient preference and natural history studies.
• Integrate affiliate and market-specific payer requirements into global evidence generation plans.
• Contribute to scientific publications, congress presentations, external partnerships, and thought leadership activities.

Interested? For this role we're looking for:

• Master's degree or PhD in Health Economics, Market Access, Outcomes Research, Public Health, Epidemiology, Pharmacy, or a related field.
• At least 8 years of experience within the pharmaceutical industry, including consultancy experience where relevant.
• Strong expertise in health economic modelling, outcomes research, and payer evidence generation.
• Experience supporting HTA submissions, reimbursement strategies, and access initiatives across key markets.
• Experience working in global or matrix organizations, with above-country or intercontinental exposure highly valued.
• Strong leadership, communication, stakeholder management, and strategic thinking skills.

Are you ready to 'go beyond' to create value and make your mark for patients? If this sounds like you, then we would love to hear from you!

About us

UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are over 9.000 people in all four corners of the globe, inspired by patients and driven by science.

Why work with us?

At UCB, we don't just complete tasks, we create value. We aren't afraid to push forward, collaborate, and innovate to make our mark for patients. We have a caring, supportive culture where everyone feels included, respected, and has equal opportunities to do their best work. We 'go beyond' to create value for our patients, and always with a human focus, whether that’s on our patients, our employees, or our planet. Working for us, you will discover a place where you can grow, and have the freedom to carve your own career path to achieve your full potential.

UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable laws.

At UCB, we've embraced a hybrid-first approach to work, bringing teams together in local hubs to foster collaborative curiosity. Unless expressly stated in the description or precluded by the nature of the position, roles are hybrid with 40% of your time spent in the office.

Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on [e-mail]. Please note should your enquiry not relate to adjustments; we will not be able to support you through this channel.